Ionis Pharmaceuticals Inc (NASDAQ: IONS) is -19.13% lower on its value in year-to-date trading and has touched a low of $34.32 and a high of $54.44 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IONS stock was last observed hovering at around $41.54 in the last trading session, with the day’s loss setting it -0.63%.
Currently trading at $40.91, the stock is -4.70% and -8.36% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.18 million and changing -1.52% at the moment leaves the stock -9.87% off its SMA200. IONS registered 8.28% gain for a year compared to 6-month loss of -15.02%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -2.66% gain in the last 1 month and extending the period to 3 months gives it a -20.24%, and is -4.73% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.19% over the week and 2.50% over the month.
Ionis Pharmaceuticals Inc (IONS) has around 927 employees, a market worth around $5.96B and $788.14M in sales. Profit margin for the company is -46.44%. Distance from 52-week low is 19.20% and -24.86% from its 52-week high. The company has generated returns on investments over the last 12 months (-15.91%).
The EPS is expected to shrink by -51.09% this year
The shares outstanding are 144.34M, and float is at 133.94M with Short Float at 7.11%.
Ionis Pharmaceuticals Inc (IONS) Insider Activity
The most recent transaction is an insider sale by Baroldi Joseph, the company’s EVP, Chief Business Officer. SEC filings show that Baroldi Joseph sold 4,006 shares of the company’s common stock on Apr 16 ’24 at a price of $41.60 per share for a total of $0.17 million. Following the sale, the insider now owns 19631.0 shares.
Ionis Pharmaceuticals Inc disclosed in a document filed with the SEC on Apr 16 ’24 that Birchler Brian (EVP, Corp and Development Ops) sold a total of 905 shares of the company’s common stock. The trade occurred on Apr 16 ’24 and was made at $41.66 per share for $37698.0. Following the transaction, the insider now directly holds 46156.0 shares of the IONS stock.
Still, SEC filings show that on Feb 16 ’24, Monia Brett P (Chief Executive Officer) disposed off 387 shares at an average price of $44.49 for $17219.0. The insider now directly holds 173,751 shares of Ionis Pharmaceuticals Inc (IONS).
